Notice
- Important: This guidance is under active development by NHS England and content may be added or updated on a regular basis.
- This Implementation Guide is currently in Draft and SHOULD NOT be used for development or active implementation without express direction from the NHS England Genomics Unit.
CodeSystem DGTS Test Package Modality Genomics
| Usage |
|---|
CodeSystem used to identify the clinical modality or testing domain associated with a genomic test package. |
HTML View
Concepts
This code system https://fhir.nhs.uk/CodeSystem/DGTS-testpackage-modality defines the following codes:
Table View
| CodeSystem.id[0] | DGTS-testpackagemodality-genomics |
| CodeSystem.url[0] | https://fhir.nhs.uk/CodeSystem/DGTS-testpackage-modality |
| CodeSystem.version[0] | 0.1.0 |
| CodeSystem.name[0] | DGTSTestPackageModality |
| CodeSystem.title[0] | DGTS Test Package Modality |
| CodeSystem.status[0] | draft |
| CodeSystem.experimental[0] | False |
| CodeSystem.date[0] | 2026-06-15T00:00:00+00:00 |
| CodeSystem.publisher[0] | NHS England |
| CodeSystem.contact[0].name[0] | NHS England |
| CodeSystem.contact[0].telecom[0].system[0] | |
| CodeSystem.contact[0].telecom[0].value[0] | interoperabilityteam@nhs.net |
| CodeSystem.contact[0].telecom[0].use[0] | work |
| CodeSystem.description[0] | CodeSystem used to identify the clinical modality or testing domain associated with a genomic test package. |
| CodeSystem.purpose[0] | Defines the categories of genomic testing services available through the Digital Genomic Test Service (DGTS). |
| CodeSystem.copyright[0] | Copyright © 2026+ NHS England Licensed under the Apache License, Version 2.0 (the \"License\"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an \"AS IS\" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html. |
| CodeSystem.caseSensitive[0] | True |
| CodeSystem.content[0] | complete |
| CodeSystem.count[0] | 7 |
| CodeSystem.concept[0].code[0] | solid-cancer |
| CodeSystem.concept[0].display[0] | Solid Cancer |
| CodeSystem.concept[0].definition[0] | Genomic testing of cancers that form solid tumours in various organs or tissues to identify genetic mutations, guide targeted treatments, predict prognosis or assess risk for inherited cancer syndromes. |
| CodeSystem.concept[1].code[0] | haematological-malignancies |
| CodeSystem.concept[1].display[0] | Haematological Malignancies |
| CodeSystem.concept[1].definition[0] | Genomic testing of blood cancers to detect specific genetic abnormalities, helping to refine diagnosis, prognosis, treatment strategies and monitoring. |
| CodeSystem.concept[2].code[0] | rare-and-inherited-disease |
| CodeSystem.concept[2].display[0] | Rare and Inherited Disease |
| CodeSystem.concept[2].definition[0] | Genetic testing to identify pathogenic variants causing rare genetic disorders, often used in diagnosing conditions inherited from parents or assessing genetic risks in families. |
| CodeSystem.concept[3].code[0] | inherited-cancer |
| CodeSystem.concept[3].display[0] | Inherited Cancer |
| CodeSystem.concept[3].definition[0] | Genetic testing to detect mutations that predispose individuals to cancers passed through families, used to assess cancer risk and inform preventive measures. |
| CodeSystem.concept[4].code[0] | pharmacogenomics |
| CodeSystem.concept[4].display[0] | Pharmacogenomics |
| CodeSystem.concept[4].definition[0] | Genetic testing to assess how an individual's genetic makeup affects their response to medications, guiding drug selection and dosage to improve efficacy and reduce adverse reactions. |
| CodeSystem.concept[5].code[0] | polygenic-risk-scores |
| CodeSystem.concept[5].display[0] | Polygenic Risk Scores |
| CodeSystem.concept[5].definition[0] | Genetic testing to aid calculation based on multiple genetic variants to estimate an individual's risk of developing complex diseases, often used alongside lifestyle and environmental factors for risk prediction. |
| CodeSystem.concept[6].code[0] | sample-storage |
| CodeSystem.concept[6].display[0] | Sample storage |
| CodeSystem.concept[6].definition[0] | Sample to be stored by the Genomic Laboratory Hub (GLH) for future genetic testing. |
XML View
</telecom>
</contact>
<description value="CodeSystem used to identify the clinical modality or testing domain associated with a genomic test package." />
<purpose value="Defines the categories of genomic testing services available through the Digital Genomic Test Service (DGTS)." />
<copyright value="Copyright © 2026+ NHS England Licensed under the Apache License, Version 2.0 (the \"License\"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an \"AS IS\" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html." />
<definition value="Genomic testing of cancers that form solid tumours in various organs or tissues to identify genetic mutations, guide targeted treatments, predict prognosis or assess risk for inherited cancer syndromes." />
</concept>
<definition value="Genomic testing of blood cancers to detect specific genetic abnormalities, helping to refine diagnosis, prognosis, treatment strategies and monitoring." />
</concept>
<definition value="Genetic testing to identify pathogenic variants causing rare genetic disorders, often used in diagnosing conditions inherited from parents or assessing genetic risks in families." />
</concept>
<definition value="Genetic testing to detect mutations that predispose individuals to cancers passed through families, used to assess cancer risk and inform preventive measures." />
</concept>
<definition value="Genetic testing to assess how an individual's genetic makeup affects their response to medications, guiding drug selection and dosage to improve efficacy and reduce adverse reactions." />
</concept>
<definition value="Genetic testing to aid calculation based on multiple genetic variants to estimate an individual's risk of developing complex diseases, often used alongside lifestyle and environmental factors for risk prediction." />
</concept>
<definition value="Sample to be stored by the Genomic Laboratory Hub (GLH) for future genetic testing." />
</concept>
</CodeSystem>
JSON View
{
{
]
}
],
"description": "CodeSystem used to identify the clinical modality or testing domain associated with a genomic test package.",
"purpose": "Defines the categories of genomic testing services available through the Digital Genomic Test Service (DGTS).",
"copyright": "Copyright © 2026+ NHS England Licensed under the Apache License, Version 2.0 (the \\\"License\\\"); you may not use this file except in compliance with the License. You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0 Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an \\\"AS IS\\\" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License. HL7® FHIR® standard Copyright © 2011+ HL7 The HL7® FHIR® standard is used under the FHIR license. You may obtain a copy of the FHIR license at https://www.hl7.org/fhir/license.html.",
{
"definition": "Genomic testing of cancers that form solid tumours in various organs or tissues to identify genetic mutations, guide targeted treatments, predict prognosis or assess risk for inherited cancer syndromes."
},
{
"definition": "Genomic testing of blood cancers to detect specific genetic abnormalities, helping to refine diagnosis, prognosis, treatment strategies and monitoring."
},
{
"definition": "Genetic testing to identify pathogenic variants causing rare genetic disorders, often used in diagnosing conditions inherited from parents or assessing genetic risks in families."
},
{
"definition": "Genetic testing to detect mutations that predispose individuals to cancers passed through families, used to assess cancer risk and inform preventive measures."
},
{
"definition": "Genetic testing to assess how an individual's genetic makeup affects their response to medications, guiding drug selection and dosage to improve efficacy and reduce adverse reactions."
},
{
"definition": "Genetic testing to aid calculation based on multiple genetic variants to estimate an individual's risk of developing complex diseases, often used alongside lifestyle and environmental factors for risk prediction."
},
{
}
]
}